v3.26.3
Stockholders' Equity - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 19, 2026
Aug. 07, 2024
May 31, 2024
Jun. 19, 2021
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Jan. 07, 2025
Sep. 12, 2024
Dec. 15, 2022
Aug. 10, 2021
Class of Stock [Line Items]                          
Dividends         $ 868,527 $ 707,101 $ 2,315,045 $ 707,101          
Preferred stock issued (in shares)         0   0   0        
Options, grant (in shares)             0 0          
Stock based compensation for stock options         $ 8,000 22,000 $ 25,000 $ 67,000          
Net of estimated forfeitures percentage             24.00%            
Share price (in dollars per share)         $ 17.58   $ 17.58            
Proceeds from exercise of stock options             $ 41,250 64,591          
Exercise of stock options (in shares)             18,333            
Purchase of common stock (in shares)             20,828            
Estimated fair value of unamortized compensation (in shares)         75,388   75,388            
Stock option awards         $ 8,000   $ 8,000            
Remaining weighted-average vesting period             3 months 7 days            
Stock based compensation for grants totataling         645,000 398,000 $ 1,912,000 1,148,000          
Unamortized compensation cost         1,785,971   $ 1,785,971            
Unamortized compensation cost, period for recognition             1 year 4 months 13 days            
Maximum number of shares per employee       5,000                  
Stock-based compensation expense         $ 10,000 $ 10,000 $ 27,000 26,000          
Warrants issued to purchase common stock (in shares)             969,525            
Class of warrant exercise price (in dollars per share)         $ 1.00   $ 1.00            
Common stock shares authorized         $ 993,200   $ 993,200            
Warrants, term                       36 months 15 days  
Warrants, extended term                     21 months 15 days    
Aggregate offering price for ATM program                   $ 25,000,000      
Share repurchase program authorized amount (in shares) 1,000,000                        
Share repurchase program, period in force 2 years                        
Company acquired a total (in shares)             19,446            
Payments for repurchase of common stock             $ 291,833 $ 0          
Employee Stock                          
Class of Stock [Line Items]                          
Common shares authorized for grant under the Plan (in shares)                         750,000
2014 Equity Participation Plan                          
Class of Stock [Line Items]                          
Common shares authorized for grant under the Plan (in shares)         1,900,000   1,900,000            
Number of options outstanding, Granted (in shares)             0            
2024 Equity Participation Plan                          
Class of Stock [Line Items]                          
Common shares authorized for grant under the Plan (in shares)   1,000,000                      
Expiration period   10 years                      
Options, grant (in shares)             325,410            
Number of options outstanding, Granted (in shares)             0            
2024 Equity Participation Plan | Options Granted to 10% Shareholder                          
Class of Stock [Line Items]                          
Expiration period   5 years                      
2024 Equity Participation Plan | Non-Statutory Stock Options                          
Class of Stock [Line Items]                          
Expiration period   10 years                      
ATM Program                          
Class of Stock [Line Items]                          
Offering price     $ 16,400,000                    
Remaining capacity to sell additional common stock         $ 15,945,937   $ 15,945,937